| abstract |
FIELD: medicine, neurology. SUBSTANCE: the present innovation deals with treating Parkinson disease, atherosclerotic encephalopathy accompanied by disorders of intellect and memory, functional pain syndromes of face and mouth cavity. The method deals with carrying out electroimpact upon cerebral tissue daily for 10 d at preliminary body premedication due to intravenous injection of metacin at 0.5- 1.0 ml quantity and short-term mononarcosis as dithilin at 0.3-0.5 mg/kg patient's body weight and artificial pulmonary ventilation. Moreover, electroimpact should be conducted due to either bilateral or monopolar application of electrodes onto patient's head at 850 mA current power at 27-40 Hz frequency for 0.1- 1.0 sec at sparing set of impulses amplitude followed by control inspection for the patient. Moreover, before each seance of electroimpact one should perform medicinal stimulation of these neurotransmitters. EFFECT: optimal complex therapy in patients. 1 cl |